vs

Side-by-side financial comparison of Koppers Holdings Inc. (KOP) and Sotera Health Co (SHC). Click either name above to swap in a different company.

Koppers Holdings Inc. is the larger business by last-quarter revenue ($432.7M vs $303.4M, roughly 1.4× Sotera Health Co). Sotera Health Co runs the higher net margin — 11.5% vs 6.9%, a 4.6% gap on every dollar of revenue. On growth, Sotera Health Co posted the faster year-over-year revenue change (4.6% vs -9.3%). Sotera Health Co produced more free cash flow last quarter ($52.4M vs $28.5M). Over the past eight quarters, Sotera Health Co's revenue compounded faster (10.6% CAGR vs -6.7%).

Koppers is a global chemical and materials company based in Pittsburgh, Pennsylvania, United States. Its headquarters is an art-deco 1920s skyscraper, the Koppers Tower.

Sotera Health Co is a global provider of end-to-end medical safety solutions. It offers sterilization services, analytical laboratory testing, and regulatory advisory support for medical device manufacturers, pharmaceutical firms, and food and consumer product companies, helping clients meet industry standards and ensure product safety for end users worldwide.

KOP vs SHC — Head-to-Head

Bigger by revenue
KOP
KOP
1.4× larger
KOP
$432.7M
$303.4M
SHC
Growing faster (revenue YoY)
SHC
SHC
+13.8% gap
SHC
4.6%
-9.3%
KOP
Higher net margin
SHC
SHC
4.6% more per $
SHC
11.5%
6.9%
KOP
More free cash flow
SHC
SHC
$23.9M more FCF
SHC
$52.4M
$28.5M
KOP
Faster 2-yr revenue CAGR
SHC
SHC
Annualised
SHC
10.6%
-6.7%
KOP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
KOP
KOP
SHC
SHC
Revenue
$432.7M
$303.4M
Net Profit
$29.7M
$34.8M
Gross Margin
25.6%
54.7%
Operating Margin
11.5%
23.2%
Net Margin
6.9%
11.5%
Revenue YoY
-9.3%
4.6%
Net Profit YoY
391.2%
182.8%
EPS (diluted)
$1.44
$0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KOP
KOP
SHC
SHC
Q4 25
$432.7M
$303.4M
Q3 25
$485.3M
$311.3M
Q2 25
$504.8M
$294.3M
Q1 25
$456.5M
$254.5M
Q4 24
$477.0M
$290.2M
Q3 24
$554.3M
$285.5M
Q2 24
$563.2M
$276.6M
Q1 24
$497.6M
$248.2M
Net Profit
KOP
KOP
SHC
SHC
Q4 25
$29.7M
$34.8M
Q3 25
$23.8M
$48.4M
Q2 25
$16.4M
$8.0M
Q1 25
$-13.9M
$-13.3M
Q4 24
$-10.2M
$12.3M
Q3 24
$22.8M
$17.0M
Q2 24
$26.8M
$8.8M
Q1 24
$13.0M
$6.3M
Gross Margin
KOP
KOP
SHC
SHC
Q4 25
25.6%
54.7%
Q3 25
24.1%
57.0%
Q2 25
22.6%
56.6%
Q1 25
23.2%
53.2%
Q4 24
17.5%
56.6%
Q3 24
21.9%
55.4%
Q2 24
21.6%
55.2%
Q1 24
19.3%
51.2%
Operating Margin
KOP
KOP
SHC
SHC
Q4 25
11.5%
23.2%
Q3 25
10.7%
23.4%
Q2 25
7.7%
6.4%
Q1 25
5.9%
-5.8%
Q4 24
1.3%
30.0%
Q3 24
9.0%
28.2%
Q2 24
10.2%
27.8%
Q1 24
7.0%
21.4%
Net Margin
KOP
KOP
SHC
SHC
Q4 25
6.9%
11.5%
Q3 25
4.9%
15.5%
Q2 25
3.2%
2.7%
Q1 25
-3.0%
-5.2%
Q4 24
-2.1%
4.2%
Q3 24
4.1%
6.0%
Q2 24
4.8%
3.2%
Q1 24
2.6%
2.5%
EPS (diluted)
KOP
KOP
SHC
SHC
Q4 25
$1.44
$0.12
Q3 25
$1.17
$0.17
Q2 25
$0.81
$0.03
Q1 25
$-0.68
$-0.05
Q4 24
$-0.47
$0.05
Q3 24
$1.09
$0.06
Q2 24
$1.25
$0.03
Q1 24
$0.59
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KOP
KOP
SHC
SHC
Cash + ST InvestmentsLiquidity on hand
$344.6M
Total DebtLower is stronger
$928.3M
$2.1B
Stockholders' EquityBook value
$574.0M
$606.0M
Total Assets
$1.9B
$3.3B
Debt / EquityLower = less leverage
1.62×
3.53×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KOP
KOP
SHC
SHC
Q4 25
$344.6M
Q3 25
$299.2M
Q2 25
$332.4M
Q1 25
$304.4M
Q4 24
$277.2M
Q3 24
$306.7M
Q2 24
$246.1M
Q1 24
$261.1M
Total Debt
KOP
KOP
SHC
SHC
Q4 25
$928.3M
$2.1B
Q3 25
$932.9M
$2.1B
Q2 25
$977.5M
$2.2B
Q1 25
$989.0M
$2.2B
Q4 24
$939.5M
$2.2B
Q3 24
$989.4M
$2.2B
Q2 24
$1.0B
$2.2B
Q1 24
$877.6M
$2.2B
Stockholders' Equity
KOP
KOP
SHC
SHC
Q4 25
$574.0M
$606.0M
Q3 25
$545.6M
$550.5M
Q2 25
$526.8M
$511.3M
Q1 25
$498.0M
$414.1M
Q4 24
$488.7M
$404.9M
Q3 24
$532.3M
$470.2M
Q2 24
$509.2M
$422.8M
Q1 24
$505.8M
$429.4M
Total Assets
KOP
KOP
SHC
SHC
Q4 25
$1.9B
$3.3B
Q3 25
$1.9B
$3.2B
Q2 25
$1.9B
$3.2B
Q1 25
$1.9B
$3.1B
Q4 24
$1.9B
$3.1B
Q3 24
$2.0B
$3.1B
Q2 24
$1.9B
$3.1B
Q1 24
$1.8B
$3.1B
Debt / Equity
KOP
KOP
SHC
SHC
Q4 25
1.62×
3.53×
Q3 25
1.71×
3.89×
Q2 25
1.86×
4.34×
Q1 25
1.99×
5.36×
Q4 24
1.92×
5.49×
Q3 24
1.86×
4.73×
Q2 24
1.97×
5.26×
Q1 24
1.74×
5.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KOP
KOP
SHC
SHC
Operating Cash FlowLast quarter
$45.1M
$103.1M
Free Cash FlowOCF − Capex
$28.5M
$52.4M
FCF MarginFCF / Revenue
6.6%
17.3%
Capex IntensityCapex / Revenue
3.8%
16.7%
Cash ConversionOCF / Net Profit
1.52×
2.96×
TTM Free Cash FlowTrailing 4 quarters
$67.5M
$149.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KOP
KOP
SHC
SHC
Q4 25
$45.1M
$103.1M
Q3 25
$49.6M
$71.2M
Q2 25
$50.5M
$57.4M
Q1 25
$-22.7M
$55.5M
Q4 24
$74.7M
$55.7M
Q3 24
$29.8M
$97.5M
Q2 24
$27.2M
$61.3M
Q1 24
$-12.3M
$9.7M
Free Cash Flow
KOP
KOP
SHC
SHC
Q4 25
$28.5M
$52.4M
Q3 25
$37.6M
$35.0M
Q2 25
$38.4M
$26.2M
Q1 25
$-37.0M
$35.6M
Q4 24
$56.1M
$-10.2M
Q3 24
$14.4M
$61.1M
Q2 24
$10.1M
$19.4M
Q1 24
$-38.6M
$-25.2M
FCF Margin
KOP
KOP
SHC
SHC
Q4 25
6.6%
17.3%
Q3 25
7.7%
11.2%
Q2 25
7.6%
8.9%
Q1 25
-8.1%
14.0%
Q4 24
11.8%
-3.5%
Q3 24
2.6%
21.4%
Q2 24
1.8%
7.0%
Q1 24
-7.8%
-10.2%
Capex Intensity
KOP
KOP
SHC
SHC
Q4 25
3.8%
16.7%
Q3 25
2.5%
11.6%
Q2 25
2.4%
10.6%
Q1 25
3.1%
7.8%
Q4 24
3.9%
22.7%
Q3 24
2.8%
12.7%
Q2 24
3.0%
15.2%
Q1 24
5.3%
14.1%
Cash Conversion
KOP
KOP
SHC
SHC
Q4 25
1.52×
2.96×
Q3 25
2.08×
1.47×
Q2 25
3.08×
7.21×
Q1 25
Q4 24
4.52×
Q3 24
1.31×
5.73×
Q2 24
1.01×
7.00×
Q1 24
-0.95×
1.53×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KOP
KOP

Other$127.8M30%
Railroad Treated Products$119.0M28%
Utility Poles$79.8M18%
Pitch And Related Products$74.1M17%
Carbon Black Feedstock And Distillates$14.4M3%
Railroad Infrastructure Products And Services$9.9M2%
Phthalic Anhydride Naphthalene And Other Chemicals$7.7M2%

SHC
SHC

Transferred At Point In Time$198.4M65%
Nelson Labs$55.2M18%
Nordion$49.8M16%

Related Comparisons